{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T18:22:12Z","timestamp":1776277332667,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007311","name":"Cleveland Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007311","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.humpath.2024.01.010","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T21:33:27Z","timestamp":1706823207000},"page":"92-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Histones and their practical application in bone tumors: Do I always need them?"],"prefix":"10.1016","volume":"147","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0542-3040","authenticated-orcid":false,"given":"John D.","family":"Reith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2024.01.010_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-981-15-8104-5_1","article-title":"Overview of histone modification","volume":"1283","author":"Zhang","year":"2021","journal-title":"Adv Exp Med Biol"},{"issue":"12","key":"10.1016\/j.humpath.2024.01.010_bib2","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1136\/jclinpath-2021-207857","article-title":"Genes of the month: H3.3 histone genes: H3F3A and H3F3B","volume":"74","author":"Kumar","year":"2021","journal-title":"J Clin Pathol"},{"issue":"1","key":"10.1016\/j.humpath.2024.01.010_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jclinpath-2021-207751","article-title":"Gene of the month: H3F3A and H3F3B","volume":"75","author":"Aldera","year":"2022","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.humpath.2024.01.010_bib4","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/978-981-15-8104-5_4","article-title":"Histone mutations and bone cancers","volume":"1283","author":"Taylor","year":"2021","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"10.1016\/j.humpath.2024.01.010_bib5","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00401-012-0998-0","article-title":"K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas","volume":"124","author":"Khuong-Quang","year":"2012","journal-title":"Acta Neuropathol"},{"issue":"7384","key":"10.1016\/j.humpath.2024.01.010_bib6","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature10833","article-title":"Driver mutations in histone H3.3 and chromatin remodeling genes in paediatric glioblastoma","volume":"482","author":"Schwartzentruber","year":"2012","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.humpath.2024.01.010_bib7","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/ng.1102","article-title":"Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas","volume":"44","author":"Wu","year":"2012","journal-title":"Nat Genet"},{"issue":"12","key":"10.1016\/j.humpath.2024.01.010_bib8","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/ng.2814","article-title":"Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone","volume":"45","author":"Behjati","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.humpath.2024.01.010_bib9","series-title":"WHO classification of tumours editorial board. WHO classification of tumours 5th ed. Soft tissue and bone tumours","first-page":"p359","article-title":"Chondroblastoma","author":"Amary","year":"2020"},{"key":"10.1016\/j.humpath.2024.01.010_bib10","series-title":"WHO classification of tumours editorial board. WHO classification of tumours 5th ed. Soft tissue and bone tumours","first-page":"p440","article-title":"Giant cell tumour of bone","author":"Flanagan","year":"2020"},{"issue":"11","key":"10.1016\/j.humpath.2024.01.010_bib11","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1097\/PAS.0000000000000512","article-title":"Mutation analysis of H3F3A and H3F3B as a diagnostic tool for giant cell tumor of bone and chondroblastoma","volume":"39","author":"Cleven","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.humpath.2024.01.010_bib12","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/modpathol.2016.212","article-title":"H3F3 mutation status of giant cell tumors of the bone, chondroblastomas and their mimics: a combined high resolution melting and pyrosequencing approach","volume":"30","author":"Kervarrec","year":"2017","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.humpath.2024.01.010_bib13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/his.12945","article-title":"The H3F3 K36M mutant antibody is a sensitive and specific marker for the diagnosis of chondroblastoma","volume":"69","author":"Amary","year":"2016","journal-title":"Histopathology"},{"issue":"2","key":"10.1016\/j.humpath.2024.01.010_bib14","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/his.13725","article-title":"Histone H3K36M mutation and trimethylation patterns in chondroblastoma","volume":"74","author":"Lu","year":"2019","journal-title":"Histopathology"},{"issue":"6","key":"10.1016\/j.humpath.2024.01.010_bib15","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/jcp-2022-208630","article-title":"Chondroblastoma; clinicopathological analyses of 307 cases from a single institution in China and the diagnostic value of the H3F3 K36M mutant antibody","volume":"76","author":"Zhao","year":"2023","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.humpath.2024.01.010_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2023.152135","article-title":"Chondroblastoma of foot bones; a clinicopathological study of 29 cases confirming the diagnostic utility of H3K36M and H3G34W antibodies at an uncommon site","volume":"65","author":"Tariq","year":"2023","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.humpath.2024.01.010_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2023.152174","article-title":"Utility of immunohistochemical expression of H3.3K36M and DOG1 in the diagnosis of chondroblastomas; an experience from a tertiary cancer referral center","volume":"66","author":"Rekhi","year":"2023","journal-title":"Ann Diagn Pathol"},{"issue":"4","key":"10.1016\/j.humpath.2024.01.010_bib18","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/10668969221105614","article-title":"Anti-histone H3.3K36M antibody is a highly sensitive and specific immunohistochemistry marker for the diagnosis of chondroblastoma. A validation based on study 136 cases comprising chondroblastoma and its mimics from a single centre in India","volume":"31","author":"Hui","year":"2023","journal-title":"Int J Surg Pathol"},{"issue":"11","key":"10.1016\/j.humpath.2024.01.010_bib19","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1038\/s41379-020-0604-2","article-title":"Clinicopathologic characterization of malignant chondroblastoma: a neoplasm with locally aggressive behavior and metastatic potential that closely mimics chondroblastoma-like osteosarcoma","volume":"33","author":"Papke","year":"2020","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.humpath.2024.01.010_bib20","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/cjp2.13","article-title":"Diagnostic value of H3F3A mutations in giant cell tumour of bone compared to osteoclast-rich mimics","volume":"1","author":"Presneau","year":"2015","journal-title":"J Pathol Clin Res"},{"key":"10.1016\/j.humpath.2024.01.010_bib21","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.humpath.2017.08.033","article-title":"Histone 3.3 mutations in giant cell tumor and giant cell-rich sarcomas of bone","volume":"68","author":"Righi","year":"2017","journal-title":"Hum Pathol"},{"issue":"12","key":"10.1016\/j.humpath.2024.01.010_bib22","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1038\/s41379-019-0318-5","article-title":"Absence of H3F3A mutation in a subset of malignant giant cell tumor of bone","volume":"32","author":"Yoshida","year":"2019","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.humpath.2024.01.010_bib23","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/his.13448","article-title":"Giant cell tumours of bone treated with denosumab: histological, immunohistochemical and H3F3A mutation analyses","volume":"72","author":"Kato","year":"2018","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2024.01.010_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2021.151882","article-title":"Clinicopathologic and molecular features of denosumab-treated giant cell tumour of bone (GCTB): analysis of 21 cases","volume":"57","author":"Yang","year":"2022","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.humpath.2024.01.010_bib25","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.humpath.2017.08.030","article-title":"Diagnostic value of histone 3 mutations in osteoclast-rich bone tumors","volume":"68","author":"Nohr","year":"2017","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.humpath.2024.01.010_bib26","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/his.13190","article-title":"H3F3A mutation in giant cell tumour of the bone is detected by immunohistochemistry using a monoclonal antibody against the G34W mutated site of the histone H3.3 variant","volume":"71","author":"L\u00fcke","year":"2017","journal-title":"Histopathology"},{"issue":"8","key":"10.1016\/j.humpath.2024.01.010_bib27","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1097\/PAS.0000000000000859","article-title":"H3F3A (histone 3.3) G34W immunohistochemistry. A reliable marker defining benign and malignant giant cell tumor of bone","volume":"41","author":"Amary","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.humpath.2024.01.010_bib28","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/PAI.0000000000000964","article-title":"Reliability and role of mutation-specific H3F3A (histone 3-3) G34W immunohistochemistry to differentiate giant cell tumor bone from it clinicoradiologic and histologic mimics: an institutional study","volume":"30","author":"Pasricha","year":"2022","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"3","key":"10.1016\/j.humpath.2024.01.010_bib29","doi-asserted-by":"crossref","first-page":"617","DOI":"10.4103\/ijpm.ijpm_265_21","article-title":"Anti-Histone H3.3 G34W antibody is a sensitive and highly specific immunohistochemistry marker for the diagnosis of Giant cell tumor of bone. A validation based on analysis of 198 cases from a single centre in India","volume":"65","author":"Kamble","year":"2022","journal-title":"Indian J Pathol Microbiol"},{"key":"10.1016\/j.humpath.2024.01.010_bib30","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.humpath.2017.11.020","article-title":"Diagnostic utility of histone H3.3 G34W, G34R, and G34V mutant-specific antibodies for giant cell tumors of bone","volume":"73","author":"Yamamoto","year":"2018","journal-title":"Hum Pathol"},{"issue":"8","key":"10.1016\/j.humpath.2024.01.010_bib31","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/cncy.22000","article-title":"Immunohistochemistry for histone H3G34W and H3K36M is highly specific for giant cell tumor of bone and chondroblastoma, respectively, in FNA and core needle biopsy","volume":"126","author":"Schaefer","year":"2018","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.humpath.2024.01.010_bib32","article-title":"Diagnosis of giant cell-rich bone tumors on core needle biopsy: a practical approach Pathol Res Pract","volume":"231","author":"Jager","year":"2022"},{"issue":"2","key":"10.1016\/j.humpath.2024.01.010_bib33","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/his.13972","article-title":"Chondroblastomas presenting in adulthood: a study of 39 patients with emphasis on histologic features and skeletal distribution","volume":"76","author":"John","year":"2020","journal-title":"Histopathology"},{"issue":"6","key":"10.1016\/j.humpath.2024.01.010_bib34","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/jcp-2023-208894","article-title":"\u2018Atypical\u2019, \u2018aggressive\u2019 or \u2018malignant\u2019 chondroblastoma? Uncertainty about uncertain malignant potential","volume":"76","author":"Reith","year":"2023","journal-title":"J Clin Pathol"},{"issue":"4","key":"10.1016\/j.humpath.2024.01.010_bib35","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.path.2021.06.010","article-title":"Giant cell-rich tumors of bone","volume":"14","author":"Hartmann","year":"2021","journal-title":"Surg Pathol Clin"},{"issue":"5","key":"10.1016\/j.humpath.2024.01.010_bib36","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/his.14401","article-title":"H3F3A-mutated giant cell tumour of bone without giant cells-clinical presentation, radiology and histology of three cases","volume":"79","author":"Leinauer","year":"2021","journal-title":"Histopathology"},{"issue":"2","key":"10.1016\/j.humpath.2024.01.010_bib37","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1177\/10668969221098090","article-title":"Giant cell tumor of bone without giant cells with a long clinical course: a case report","volume":"31","author":"Takase","year":"2023","journal-title":"Int J Surg Pathol"},{"issue":"9","key":"10.1016\/j.humpath.2024.01.010_bib38","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1007\/s00256-023-04292-w","article-title":"Giant-cell-poor giant cell tumor of bone: report of two cases and literature review","volume":"52","author":"Yakoub","year":"2023","journal-title":"Skeletal Radiol"},{"issue":"1","key":"10.1016\/j.humpath.2024.01.010_bib39","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/PAS.0000000000001555","article-title":"Immunohistochemical characterization of giant cell tumor of bone treated with denosumab. Support for osteoblastic differentiation","volume":"45","author":"Kerr","year":"2021","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.humpath.2024.01.010_bib40","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13569-017-0075-5","article-title":"Histone 3.3 hotspot mutations in conventional osteosarcomas: a comprehensive clinical and molecular characterization of six H3F3A mutated cases","volume":"7","author":"Koelsche","year":"2017","journal-title":"Clin Sarcoma Res"},{"issue":"12","key":"10.1016\/j.humpath.2024.01.010_bib41","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1097\/PAS.0000000000000715","article-title":"Histologic spectrum of giant cell tumor (GCT) of bone in patients 18 years of age and below. A study of 63 patients","volume":"40","author":"Al-Ibraheemi","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.humpath.2024.01.010_bib42","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/ajcp\/aqx155","article-title":"Giant cell tumor of bone in patients 55 years and older. A study of 34 patients","volume":"149","author":"Broehm","year":"2018","journal-title":"Am J Clin Pathol"},{"issue":"10","key":"10.1016\/j.humpath.2024.01.010_bib43","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1038\/s41379-020-0562-8","article-title":"Xanthogranulomatous epithelial tumor: report of 6 cases of a novel, potentially deceptive lesion with a predilection for young women","volume":"33","author":"Fritchie","year":"2020","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.humpath.2024.01.010_bib44","doi-asserted-by":"crossref","first-page":"163","DOI":"10.21873\/cgp.20312","article-title":"Recurrent fusion of the genes for High-mobility Group AT-hook 2 (HMGA2) and Nuclear Receptor Co-repressor 2 (NCOR2) in osteoclastic giant cell-rich tumors of bone","volume":"19","author":"Panagopoulos","year":"2022","journal-title":"Cancer Genomics Proteomics"},{"issue":"11","key":"10.1016\/j.humpath.2024.01.010_bib45","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1038\/s41379-022-01115-6","article-title":"Xanthogranulomatous epithelial tumors and keratin-positive giant cell-rich soft tissue tumors: two aspects of a single entity with frequent HMGA2-NCOR2 fusions","volume":"35","author":"Dehner","year":"2022","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2024.01.010_bib46","article-title":"Keratin-positive giant cell-rich tumor of bone harboring an HMGA2::NCOR2 fusion: two cases, including a patient with metastatic disease, and review of the literature","author":"Patton","year":"2023","journal-title":"Int J Surg Pathol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817724000108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817724000108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T21:51:44Z","timestamp":1736200304000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817724000108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":46,"alternative-id":["S0046817724000108"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2024.01.010","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histones and their practical application in bone tumors: Do I always need them?","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2024.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}